title: Priming with recombinant auxotrophic BCG expressing HIV-1 Gag, RT and Gp120 and boosting with recombinant MVA induces a robust T cell response in mice.
abstract: In previous studies we have shown that a pantothenate auxotroph of Myocbacterium bovis BCG (BCGΔpanCD) expressing HIV-1 subtype C Gag induced Gag-specific immune responses in mice and Chacma baboons after prime-boost immunization in combination with matched rMVA and VLP vaccines respectively. In this study recombinant BCG (rBCG) expressing HIV-1 subtype C reverse transcriptase and a truncated envelope were constructed using both the wild type BCG Pasteur strain as a vector and the pantothenate auxotroph. Mice were primed with rBCG expressing Gag and RT and boosted with a recombinant MVA, expressing a polyprotein of Gag, RT, Tat and Nef (SAAVI MVA-C). Priming with rBCGΔpanCD expressing Gag or RT rather than the wild type rBCG expressing Gag or RT resulted in higher frequencies of total HIV-specific CD8(+) T cells and increased numbers of T cells specific to the subdominant Gag and RT epitopes. Increasing the dose of rBCG from 10(5) cfu to 10(7) cfu also led to an increase in the frequency of responses to subdominant HIV epitopes. A mix of the individual rBCGΔpanCD vaccines expressing either Gag, RT or the truncated Env primed the immune system for a boost with SAAVI MVA-C and generated five-fold higher numbers of HIV-specific IFN-γ-spot forming cells than mice primed with rBCGΔpanCD containing an empty vector control. Priming with the individual rBCGΔpanCD vaccines or the mix and boosting with SAAVI MVA-C also resulted in the generation of HIV-specific CD4(+) and CD8(+) T cells producing IFN-γ and TNF-α and CD4(+) cells producing IL-2. The rBCG vaccines tested in this study were able to prime the immune system for a boost with rMVA expressing matching antigens, inducing robust, HIV-specific T cell responses to both dominant and subdominant epitopes in the individual proteins when used as individual vaccines or in a mix.
authors: Institute of Infectious Disease and Molecular Medicine, Albert Einstein College of Medicine, Bronx, New York, United States of America ; Division of Medical Virology, Department of Clinical Laboratory Science, Albert Einstein College of Medicine, Bronx, New York, United States of America.
authors: Rosamund
authors: R
authors: Chapman
authors: Helen
authors: H
authors: Stutz
authors: William
authors: W
authors: Jacobs
authors: Enid
authors: E
authors: Shephard
authors: Anna-Lise
authors: AL
authors: Williamson
mesh_terms: D000818:Animals; D001500:BCG Vaccine / Q000276:immunology*; D045142:Cross-Priming / Q000187:drug effects / Q000276:immunology*; D058501:Enzyme-Linked Immunospot Assay; D005260:Female; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D015497:HIV-1 / Q000276:immunology*; D007117:Immunization, Secondary; D007371:Interferon-gamma / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D009163:Mycobacterium bovis / Q000187:drug effects / Q000276:immunology; D010205:Pantothenic Acid / Q000494:pharmacology; D012194:RNA-Directed DNA Polymerase / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*; D014764:Viral Proteins / Q000276:immunology*; D054301:gag Gene Products, Human Immunodeficiency Virus / Q000276:immunology
chemical_list: D001500:BCG Vaccine; D015699:HIV Envelope Protein gp120; D014614:Vaccines, Synthetic; D014764:Viral Proteins; D054301:gag Gene Products, Human Immunodeficiency Virus; D010205:Pantothenic Acid; D007371:Interferon-gamma; D012194:RNA-Directed DNA Polymerase
references: S Afr Med J. 2012 Mar 02;102(6):452-5
references: 22668934
references: Eur J Immunol. 2011 Dec;41(12):3542-52
references: 21932450
references: J Virol. 2005 Oct;79(20):12871-9
references: 16188989
references: Infect Immun. 2008 Nov;76(11):5200-14
references: 18725418
references: J Immunol. 2005 May 1;174(9):5341-50
references: 15843531
references: Proc Natl Acad Sci U S A. 1988 May;85(9):3105-9
references: 2452443
references: J Virol. 2013 May;87(9):5151-60
references: 23449790
references: J Immunol. 1999 Aug 1;163(3):1449-56
references: 10415046
references: Vaccine. 2009 Oct 19;27(44):6116-20
references: 19715782
references: Vaccine. 2003 Oct 1;21(27-30):4153-66
references: 14505895
references: PLoS One. 2012;7(3):e32769
references: 22479338
references: AIDS Res Hum Retroviruses. 2003 Feb;19(2):133-44
references: 12639249
references: J Virol. 2012 Jun;86(12):6959-69
references: 22514340
references: J Virol. 2007 Sep;81(17):9408-18
references: 17596303
references: J Virol. 2010 Jun;84(12):5898-908
references: 20375158
references: Lancet. 2005 Oct 22-28;366(9495):1443-51
references: 16243089
references: J Immunol. 2007 Jul 1;179(1):211-20
references: 17579040
references: J Immunol. 2008 May 1;180(9):5853-61
references: 18424704
references: N Engl J Med. 2012 Apr 5;366(14):1275-86
references: 22475592
references: Vaccine. 2003 Oct 1;21(27-30):4380-9
references: 14505921
references: N Engl J Med. 2009 Dec 3;361(23):2209-20
references: 19843557
references: J Med Primatol. 2006 Aug;35(4-5):217-24
references: 16872285
references: PLoS One. 2011;6(5):e20067
references: 21603645
references: J Immunol. 2004 Mar 15;172(6):3491-500
references: 15004149
references: J Virol. 2002 May;76(9):4251-9
references: 11932390
references: J Immunol. 2009 Dec 15;183(12):7710-8
references: 19923462
references: AIDS Res Hum Retroviruses. 2008 Feb;24(2):207-17
references: 18240963
references: J Virol. 2012 Apr;86(7):3667-74
references: 22278254
references: J Immunol. 2001 Jan 1;166(1):447-57
references: 11123323
references: AIDS Res Hum Retroviruses. 2008 Feb;24(2):195-206
references: 18240957
references: J Gen Virol. 2006 Feb;87(Pt 2):399-410
references: 16432028
references: Am J Respir Crit Care Med. 2012 Aug 15;186(4):378-84
references: 22700862
references: J Bacteriol. 2000 Jul;182(13):3832-8
references: 10851001
references: J Biomed Biotechnol. 2010;2010:357370
references: 20617151
references: J Immunol. 1998 Sep 15;161(6):2985-93
references: 9743362
references: J Virol. 2009 Jun;83(11):5505-13
references: 19297477
references: Nat Rev Immunol. 2006 Dec;6(12):930-9
references: 17124514